Shengshi Tech Reports 2025 Employee Enrollment of 57, Down 1.72% Year-over-Year

May 31 News: According to data from Tianyancha, the number of insured employees at Shengshi Taike Biopharmaceutical Technology (Suzhou) Co., Ltd. in 2025 was 57, a decrease of one person compared to the 58 disclosed in 2024, representing a year-on-year decline of 1.72%. The company's workforce size has contracted slightly, while its personnel structure continues to be optimized.

(Data sourced from Tianyancha; in case of discrepancies, please refer to the actual information.)

Based on historical changes in the number of insured employees, Shengshi Taike Biopharmaceutical Technology (Suzhou) Co., Ltd. had 31 insured employees in 2018, an increase of 7 from the 24 reported in the previous period, representing a year-on-year growth of 29.17%. This marked the largest annual increase in the number of insured employees in recent years.In 2023, the number of insured employees at Shengshi Taike Biopharmaceutical Technology (Suzhou) Co., Ltd. decreased from 66 in the previous period to 56, a reduction of 10, representing a year-on-year decline of 15.15%. This marked the largest annual decrease in the number of insured employees in recent years.

Figure: Trend Chart of the Number of Insured Employees at Shengshi Taike Biopharmaceutical Technology (Suzhou) Co., Ltd.

In addition to the number of insured employees, Tianyancha also disclosed the company’s industrial and commercial registration details. Shengshi Taike Biopharmaceutical Technology (Suzhou) Co., Ltd. was established on January 25, 2010. The legal representative is Ding Juping. The industry category is manufacturing of organic chemical raw materials. The enterprise type is a joint-stock limited company (unlisted, invested or controlled by natural persons). The enterprise scale is micro-sized. The registered capital is RMB 26,498,710, and the paid-in capital is RMB 26,498,710. The registered address is Units 101 and 102, Building C11, Phase I Project of the BioBAY, No. 218 Xinghu Street, Suzhou Industrial Park, Suzhou Area, China (Jiangsu) Pilot Free Trade Zone. The shareholder information is as follows:

The number of insured employees at Shengshi Taike Biopharmaceutical Technology (Suzhou) Co., Ltd. has shown a fluctuating trend. From 2016 to 2022, the overall number of insured employees exhibited an upward trajectory, with varying degrees of growth during this period; the year-on-year growth rate reached 29.17% in 2018. However, the number of insured employees decreased by 15.15% year-on-year in 2023, and further declined by one person in 2025 compared to 2024, representing a year-on-year decrease of 1.72%. This reflects potential instability in the company's operations. The reduction in insured employees may suggest adjustments in workforce size, warranting continued attention to how future operational strategies and market performance will further impact staffing levels.

Disclaimer: The market involves risks, and investment should be approached with caution. This article was generated by an AI large language model based on public information and does not represent the views of Sina Finance. All information, data, and charts contained herein are for reference only and do not constitute any form of investment advice or basis for decision-making. For accurate information, please refer to the actual announcements. If you have any questions, please contact: biz@staff.sina.com.cn.

Responsible Editor: Xiaolang Express